Identification of Metabolism-Associated Biomarkers for Early and Precise Diagnosis of Oral Squamous Cell Carcinoma

Biomolecules. 2022 Mar 4;12(3):400. doi: 10.3390/biom12030400.

Abstract

The 5-year survival rate for oral squamous cell carcinoma (OSCC), one of the most common head and neck cancers, has not improved in the last 20 years. Poor prognosis of OSCC is the result of failure in early and precise diagnosis. Metabolic reprogramming, including the alteration of the uptake and utilisation of glucose, amino acids and lipids, is an important feature of OSCC and can be used to identify its biomarkers for early and precise diagnosis. In this review, we summarise how recent findings of rewired metabolic networks in OSCC have facilitated early and precise diagnosis of OSCC.

Keywords: biomarker; early diagnosis; metabolic reprogramming; oral squamous cell carcinoma; precise diagnosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomarkers, Tumor / metabolism
  • Carcinoma, Squamous Cell* / metabolism
  • Head and Neck Neoplasms*
  • Humans
  • Mouth Neoplasms* / metabolism
  • Squamous Cell Carcinoma of Head and Neck

Substances

  • Biomarkers, Tumor